Tenaya Therapeutics is trading at $0.42, up 8.58% in after-hours trading, with no confirmed company-specific catalyst identified. - A preliminary proxy filing dated October 13 proposes a shareholder vote on a possible 1-for-10 to 1-for-25 reverse stock split; available coverage does not establish it as the reason for the move. - The October 14 market decline is broader context, but does not explain the stock’s after-hours gain. - The cause of the rebound remains unclear.